INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Innovative FSP Solutions For Biopharma Growth And Transition
To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.
-
Breaking Barriers: Enhancing The Bioavailability Of Orally Delivered TPDs
The large, bulky structure of TPDs limits solubility and permeability. Enabling technologies like spray drying, hot melt extrusion, and nanomilling are key to formulating these challenging molecules.
-
The Defensiveness Trap In Vendor Selection And Management
In clinical research, sponsor–vendor relationships are often framed as negotiations. Yet while both sides want to achieve a successful study, the process often becomes a tug-of-war.
-
Leveraging Functional Service Providers For Drug Development Efficiency
Discover how functional service providers (FSPs) are reshaping clinical research by offering specialized expertise, flexible resources, and cost-effective solutions.
-
How To Optimize Early-Phase Drug Development10/16/2024
Do you keep hitting roadblocks? Frustrated with all the paperwork? Let us help! Learn how Altasciences can provide a more seamless and efficient drug development experience.
-
Building A High-Quality IND From Scratch With Strategic Gap Analysis8/12/2025
A biotech sponsor lacking in-house regulatory expertise engaged a partner to obtain strategic regulatory review, medical writing, project management, and electronic publishing (eCTD).
-
How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs3/17/2025
Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.
-
Travel And Payment Services: A Patient's Journey12/5/2025
Streamline patient travel and payments in your clinical trials by implementing centralized, high-quality concierge services that reduce burdens, improve satisfaction, and boost study performance.
-
Considerations For Drug-Device Combination Products In Rare Diseases8/7/2025
The development process for these products is complex, requiring careful consideration of regulatory requirements, technical feasibility, clinical efficacy, and patient-centered design.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Explore data solutions for every clinical study - whether you are engaging our comprehensive CRO services or require specific, functional solutions to support your project.
-
From regulatory pathway selection to patient recruitment challenges to navigating the volume of data to collect and clean — a rare disease therapy requires an extraordinary amount of coordination.
-
Best-in-class processes coupled with industry-leading technology to fight for your trial’s success.
-
Ropack Pharma Solutions provides a serialized supply chain that is proficient, verified and ready to safeguard your pharmaceutical product and the patients who depend on it.
-
We specialize in DDI studies, including stand-alone and 'cocktail' designs, assessing multiple CYP enzymes or transporters in single studies, from simple crossovers to complex adaptive trials.